Journal
HUMAN GENETICS
Volume 130, Issue 1, Pages 123-148Publisher
SPRINGER
DOI: 10.1007/s00439-011-1037-2
Keywords
-
Categories
Funding
- Autism Speaks
- Autism Speaks Canada
- Canadian Institutes of Health Research (CIHR)
- Institute of Genetics
- Institute of Neurosciences
- Mental Health and Addiction, Genome Canada
- Hospital for Sick Children
- Medical Research Council (UK)
- National Institute of Child Health and Human Development, NeuroDevNet
- Ontario Genomics Institute
- Ontario Ministry of Research and Innovation
- Robarts Institute (Dr. Robert Hegele-Genome Canada)
Ask authors/readers for more resources
Autism spectrum disorders (ASDs) are a group of conditions characterized by impairments in communication and reciprocal social interaction, and the presence of restricted and repetitive behaviors. The spectrum of autistic features is variable, with severity of symptoms ranging from mild to severe, sometimes with poor clinical outcomes. Twin and family studies indicate a strong genetic basis for ASD susceptibility. Recent progress in defining rare highly penetrant mutations and copy number variations as ASD risk factors has prompted early uptake of these research findings into clinical diagnostics, with microarrays becoming a 'standard of care' test for any ASD diagnostic work-up. The ever-changing landscape of the generation of genomic data coupled with the vast heterogeneity in cause and expression of ASDs (further influenced by issues of penetrance, variable expressivity, multigenic inheritance and ascertainment) creates complexity that demands careful consideration of how to apply this knowledge. Here, we discuss the scientific, ethical, policy and communication aspects of translating the new discoveries into clinical and diagnostic tools for promoting the well-being of individuals and families with ASDs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available